Free Trial
→ The AI trade Wall Street is getting dead wrong (From Behind the Markets) (Ad)tc pixel
OTCMKTS:TRUMY

Terumo 11/7/2024 Earnings Report

Terumo logo
$12.68 0.00 (0.00%)
As of 05/15/2026 03:59 PM Eastern
ProfileEarnings HistoryForecast

Terumo EPS Results

Actual EPS
$0.13
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Terumo Revenue Results

Actual Revenue
$1.68 billion
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Terumo Announcement Details

Quarter
Date
11/7/2024
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Terumo's next earnings date is estimated for Thursday, August 6, 2026, based on past reporting schedules.

Conference Call Resources

Terumo Earnings Headlines

Terumo ADR Stock Price History
May 17 at 2:26 PM  |  investing.comhttps://www.investing.com/equities/terumo-adr-historical-data
Terumo Corporation (TRUMY) Q4 2026 Earnings Call Transcript
May 17 at 2:26 PM  |  seekingalpha.comhttps://seekingalpha.com/article/4905155-terumo-corporation-trumy-q4-2026-earnings-call-transcript
Your book attached
Veteran trader Bill Poulos is giving away his 'Simple Options Trading For Beginners' book - normally $29.97 - at no charge. Inside, he reveals the one options technique that took him 11 years to find, why more strategies often lead to more losses, and the 10-minute nightly routine that replaced his 8-hour trading days.tc pixel
 |  Profits Run (Ad)
Terumo (OTCMKTS:TRUMY) Trading 5.1% Higher - Here's What Happened
May 17 at 4:45 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30783433
Reviewing Else Nutrn (OTCMKTS:BABYF) and Terumo (OTCMKTS:TRUMY)
May 15 at 3:38 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30779151
Terumo Corporation (TRUMY) Q3 2026 Earnings Call Transcript
February 13, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4870046-terumo-corporation-trumy-q3-2026-earnings-call-transcript
See More Terumo Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Terumo? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Terumo and other key companies, straight to your email.

About Terumo

Terumo (OTCMKTS:TRUMY) Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags. Through its Terumo BCT subsidiary, the company also provides apheresis, blood component management and cell therapy technologies used by blood banks, transfusion services and cell-therapy developers. Terumo’s portfolio emphasizes single-use medical devices and clinically oriented systems designed to improve procedural outcomes and patient safety.

Founded in the early 20th century and headquartered in Tokyo, Terumo has grown into a multinational supplier with operations and sales networks across Asia, the Americas and Europe. The company distributes products globally through a combination of regional subsidiaries, direct sales teams and distribution partners, serving hospitals, specialty clinics and blood centers. As a publicly listed Japanese corporation, Terumo also maintains an American depositary receipt (ADR) listing that enables trading on overseas markets.

View Terumo Profile
Earnings Tools